284 related articles for article (PubMed ID: 12197350)
1. Effects of single-dose praziquantel on morbidity and mortality resulting from intestinal schistosomiasis.
Kheir MM; Baraka OZ; el-Tom IA; Mukhtar MM; Homieda MM
East Mediterr Health J; 2000; 6(5-6):926-31. PubMed ID: 12197350
[TBL] [Abstract][Full Text] [Related]
2. Reduction in prevalence, intensity of infection and morbidity due to Schistosoma mansoni infection in a community following treatment with praziquantel.
Sukwa TY; Bulsara MK; Wurapa FK
J Trop Med Hyg; 1987 Aug; 90(4):205-11. PubMed ID: 3116277
[TBL] [Abstract][Full Text] [Related]
3. Intestinal schistosomiasis of Ijinga Island, north-western Tanzania: prevalence, intensity of infection, hepatosplenic morbidities and their associated factors.
Mueller A; Fuss A; Ziegler U; Kaatano GM; Mazigo HD
BMC Infect Dis; 2019 Oct; 19(1):832. PubMed ID: 31590657
[TBL] [Abstract][Full Text] [Related]
4. Some factors affecting prevalence of and immune responses to Schistosoma mansoni in schoolchildren in Gorgora, northwest Ethiopia.
Degu G; Mengistu G; Jones J
Ethiop Med J; 2002 Oct; 40(4):345-52. PubMed ID: 12596654
[TBL] [Abstract][Full Text] [Related]
5. Changes in prevalence, intensity of infection and morbidity due to Schistosoma japonicum infection in a community following a single treatment with praziquantel.
Zhao G; Jiang Q; Wasley A; Zhang S; ljWu Z; Liu Z; Yuan H
Trop Geogr Med; 1995; 47(6):289-92. PubMed ID: 8650742
[TBL] [Abstract][Full Text] [Related]
6. Schistosomiasis mansoni in Burundi: progress in its control since 1985.
Engels D; Ndoricimpa J; Gryseels B
Bull World Health Organ; 1993; 71(2):207-14. PubMed ID: 8490984
[TBL] [Abstract][Full Text] [Related]
7. Infection with Schistosoma mansoni in two different endemic areas: a comparative population-based study in Elziedab and Gezira-Managil irrigation schemes, Sudan.
Eltoum IA; Sulaiman SM; Elturabi H; Mahgoub E; Homeida MM
J Trop Med Hyg; 1993 Apr; 96(2):100-6. PubMed ID: 8459482
[TBL] [Abstract][Full Text] [Related]
8. [Schistosomiasis mansoni infection in a hyperendemic region of midwestern Madagascar: epidemiology, morbidity and secondary effects of praziquantel treatment].
Boisier P; Ravaoalimalala VA; Serieye J; Roux J; Esterre P
Arch Inst Pasteur Madagascar; 1994; 61(1):43-8. PubMed ID: 7778950
[TBL] [Abstract][Full Text] [Related]
9. Regression of hepatosplenomegaly in Kenyan school-aged children after praziquantel treatment and three years of greatly reduced exposure to Schistosoma mansoni.
Vennervald BJ; Booth M; Butterworth AE; Kariuki HC; Kadzo H; Ireri E; Amaganga C; Kimani G; Kenty L; Mwatha J; Ouma JH; Dunne DW
Trans R Soc Trop Med Hyg; 2005 Feb; 99(2):150-60. PubMed ID: 15607341
[TBL] [Abstract][Full Text] [Related]
10. [Reinfection with Schistosoma haematobium and mansoni despite repeated praziquantel office treatment in Niger, Mali].
Dabo A; Doucoure B; Koita O; Diallo M; Kouriba B; Klinkert MQ; Doumbia S; Doumbo O
Med Trop (Mars); 2000; 60(4):351-5. PubMed ID: 11436587
[TBL] [Abstract][Full Text] [Related]
11. Assessment of Schistosoma mansoni induced intestinal inflammation by means of eosinophil cationic protein, eosinophil protein X and myeloperoxidase before and after treatment with praziquantel.
Reimert CM; Tukahebwa EM; Kabatereine NB; Dunne DW; Vennervald BJ
Acta Trop; 2008 Mar; 105(3):253-9. PubMed ID: 18177822
[TBL] [Abstract][Full Text] [Related]
12. Sequential analysis of helminth egg output in human stool samples following albendazole and praziquantel administration.
Scherrer AU; Sjöberg MK; Allangba A; Traoré M; Lohourignon LK; Tschannen AB; N'Goran EK; Utzinger J
Acta Trop; 2009 Mar; 109(3):226-31. PubMed ID: 19070583
[TBL] [Abstract][Full Text] [Related]
13. Impact of population-based selective chemotherapy on prevalence and intensity of Schistosoma mansoni infections in the Nile Delta: Kafr El Sheikh.
Barakat R; el Masry AG; Farghaly A; el Morshidy HN; elSayed MK; Husein MH; Miller FD
Trop Geogr Med; 1995; 47(6):266-70. PubMed ID: 8650737
[TBL] [Abstract][Full Text] [Related]
14. [Clinico-epidemiological investigation of schistosome-induced hepatosplenomegaly: a community-based study in Jishan, Xinjian County, Jiangxi].
Wu GL; Yuan JH; He Q; Wu FD; Zhang SJ; Wei RM; Li GH; Xiang JY; Jiang XL; Wiest PM
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1991; 9(4):274-7. PubMed ID: 1802452
[TBL] [Abstract][Full Text] [Related]
15. Repeated praziquantel treatments remodel the genetic and spatial landscape of schistosomiasis risk and transmission.
Barbosa LM; Reis EA; Dos Santos CR; Costa JM; Carmo TM; Aminu PT; Pitanga TN; Ponce-Terashima R; Blank WA; Silva LK; Reis MG; Blanton RE
Int J Parasitol; 2016 May; 46(5-6):343-50. PubMed ID: 26953255
[TBL] [Abstract][Full Text] [Related]
16. High levels of Schistosoma mansoni infections among schoolchildren in central Sudan one year after treatment with praziquantel.
Ahmed AM; El Tash LA; Mohamed EY; Adam I
J Helminthol; 2012 Jun; 86(2):228-32. PubMed ID: 21729382
[TBL] [Abstract][Full Text] [Related]
17. [Analysis on morbidity and chemotherapy effects of Schistosoma japonicum infection in fishermen on Dongting Lake].
Zeng QR; Hou JW; He YK; Luo XS; Zhang SK; Shu HP; Sima YX; Yu XL; Li YS
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2004 Aug; 22(4):199-203. PubMed ID: 15587151
[TBL] [Abstract][Full Text] [Related]
18. Associations between specific antibody responses and resistance to reinfection in a Senegalese population recently exposed to Schistosoma mansoni.
Vereecken K; Naus CW; Polman K; Scott JT; Diop M; Gryseels B; Kestens L
Trop Med Int Health; 2007 Mar; 12(3):431-44. PubMed ID: 17313515
[TBL] [Abstract][Full Text] [Related]
19. Morbidity associated with schistosomiasis before and after treatment in young children in Rusinga Island, western Kenya.
Davis SM; Wiegand RE; Mulama F; Kareko EI; Harris R; Ochola E; Samuels AM; Rawago F; Mwinzi PM; Fox LM; Odiere MR; Won KY
Am J Trop Med Hyg; 2015 May; 92(5):952-8. PubMed ID: 25758651
[TBL] [Abstract][Full Text] [Related]
20. Hepatosplenomegaly in Kenyan schoolchildren: exacerbation by concurrent chronic exposure to malaria and Schistosoma mansoni infection.
Wilson S; Vennervald BJ; Kadzo H; Ireri E; Amaganga C; Booth M; Kariuki HC; Mwatha JK; Kimani G; Ouma JH; Muchiri E; Dunne DW
Trop Med Int Health; 2007 Dec; 12(12):1442-9. PubMed ID: 18076550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
